Analysis of the p53 gene by PCR-SSCP in ten cases of Wilms’ tumor
Keywords:
Wilms’ tumor, p53 gene, PCR-SSCP, Solid tumorsAbstract
CONTEXT: Mutations of the p53 tumor suppressor gene are the most frequent alterations observed in human neoplasias affecting adults. In pediatric oncology, however, they have seldom been identified. Wilms’ tumor is a renal neoplasia commonly occurring in children and is associated with mutations of the WT1 gene. The correlation between Wilms’ tumor and alterations of the p53 gene has not been well established, with a low frequency of mutations having been reported in this type of tumor. Mutation may be associated with advanced stage disease and unfavorable histology. OBJECTIVE: To screen for mutations of the p53 gene by the PCR-SSCP method and DNA sequencing in cases of Wilms’ tumor sug-gestive of mutation. DESIGN: Case Report. CASE REPORT: Evaluations of exons 5-9 of the p53 gene in DNA samples extracted by PCR-SSCP from 10 Wilms’ tumors in children at different stages, and DNA sequencing. Changes in SSCP analy-sis were observed in exon 8 in two samples. The probable muta-tions were not confirmed by DNA sequencing. The absence of point mutations in p53 gene observed in the 10 samples of Wilms’ tumor studied agrees with literature data, with DNA sequencing being of fundamental importance for the confirmation of possible mutations.
Downloads
References
Fields S, Jang S. Presence of a potent transcription activating sequence in the p53 protein. Science 1990;249:1046-9.
Levine A, Momand J, Finlay C. The p53 tumor suppressor gene. Nature (Lond) 1991;351:453-6.
Vogelstein B, Kinzler K. p53 function and dysfunction. Cell 1992;70:523-6.
Chang F, Syrjanen S, Syrjanen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 1995;13:1009-22.
Levine AJ. The p53 tumor suppressor gene. N Engl J Med 1992;326:1350-2.
Kusafuka T, Fuzukawa M, Oue T, Komoto Y, Yoneda A, Okada A. Mutation analysis of the p53 gene in childhood malignant solid tumors. J Pediat Surg 1997;32:1175-80.
Breslow N, Beckwith JB, Ciol M, Sharples K. Age distribution of Wilms tumor: report from the National Wilms Tumor Study. Cancer Res 1988;48:1653-7.
Clericuzio C. Clinical phenotypes and Wilms tumor. Med Pediat Oncol 1993;21:182-7.
Malkin D, Sexsmith E, Yeger H, Williams BRG, Coppes MJ. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms tumor. Cancer Res 1994;54:2077-9.
Bardeesy N, Falkoff D, Petruzzi M, et al. Anaplastic Wilms tumor: a subtype displaying poor prognosis harbors p53 gene mutations. Nature Genet 1994;7:91-7.
DAnglio GJ, Evans A, Breslow N, et al. Treatment of Wilms tumor: results of the third National Wilms Tumor Study. Cancer (Phila) 1989;64:349-60.
Sambrook J, Fritsch EF, Maniats T. Molecular Cloning: a laboratory manual. 2 nd ed. Cold Spring Harbor, NY: Cold Spring Harbor; 1989.
Hsiao M, Yu AA, Yeargin J, Ku D, Haas M. Nonhereditary p53 mutations in t-cell acute lymphoblastic leukemia are associated with relapse phase. Blood 1994;83:2922-30.
Hayashi K. PCR-SSCP. A simple and sensitive method for detection of mutations in the genomic DNA. PCR Meth Applications 1991;1:34-8.
Greenblatt M, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
Waber PG, Chen J, Nisen PD. Infrequency of ras, p53, WT 11 or RB gene alterations in Wilms tumor. Cancer 1993;72:3732-8.
